The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun
Abstract
The transformation suppressor gene Pdcd4 (programmed cell death gene 4) inhibits the tumor-promoter mediated transformation of mouse keratinocytes and has recently been implicated as a potential tumor suppressor gene in the development of human lung cancer. Biochemical analysis has suggested that the Pdcd4 protein is involved in protein translation as well as in nuclear events. Recent work has shown that Pdcd4 suppresses the transactivation of AP-1 responsive promoters by c-Jun, suggesting that the transformation-suppressor activity of Pdcd4 might be due, at least in part, to the inhibition of c-Jun activity. Here, we have addressed how Pdcd4 inhibits c-Jun. We show that Pdcd4 interferes with the phosphorylation of c-Jun by Jun N-terminal kinase (JNK). The inhibition of c-Jun phosphorylation by Pdcd4 appears not to be due to a general suppression of JNK activity, our data rather suggest that Pdcd4 interacts with c-Jun and thereby blocks phosphorylation of c-Jun. In addition to affecting c-Jun phosphorylation, Pdcd4 blocks the recruitment of the coactivator p300 by c-Jun. Taken together, our results strongly suggest that Pdcd4 is directly involved in the regulation of c-Jun activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PDCD4 was shown to inhibit the activation of c-Jun by suppressing the JNK-activation in avian QT6 cells [34] and to suppress the expression of the upstream kinase MAP4K1 in RKO human colon carcinoma cells [33].”
From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [34]
Citations
Cites
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Hibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 919
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., & Karin, M. (1991) · Nature · doi:10.1038/354494a0 · Cited by 789
Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain
Binétruy, B., Smeal, T., & Karin, M. (1991) · Nature · doi:10.1038/351122a0 · Cited by 598
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494
c-Jun Can Recruit JNK to Phosphorylate Dimerization Partners via Specific Docking Interactions
Kallunki, T., Deng, T., Hibi, M., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81999-6 · Cited by 492
The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene
Ness, S. A., Marknell, Å., & Graf, T. (1989) · Cell · doi:10.1016/0092-8674(89)90767-8 · Cited by 453
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail
Moscovici, C., Moscovici, M. G., Jimenez, H., Lai, M. M. C., Hayman, M. J., & Vogt, P. K. (1977) · Cell · doi:10.1016/0092-8674(77)90320-8 · Cited by 402
Cited by
Sorted by citations
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
miR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987
Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer
Mudduluru, G., George-William, J. N., Muppala, S., Asangani, I. A., Kumarswamy, R., Nelson, L. D., & Allgayer, H. (2011) · Bioscience Reports · doi:10.1042/bsr20100065 · Cited by 332
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Lankat–Buttgereit, B., & Göke, R. (2009) · Biology of the Cell · doi:10.1042/bc20080191 · Cited by 315
Stagakis, E., Bertsias, G. K., Verginis, P., Νάκου, Μ., Hatziapostolou, M., Kritikos, H. D., Iliopoulos, D., & Boumpas, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139857 · Cited by 307
Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer
Shibuya, H., Iinuma, H., Shimada, R., Horiuchi, A., & Watanabe, T. (2010) · Oncology · doi:10.1159/000323283 · Cited by 254
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation
Talotta, F., Cimmino, A., Matarazzo, M. R., Casalino, L., De Vita, G., D'Esposito, M., Di Lauro, R., & Verde, P. (2009) · Oncogene · doi:10.1038/onc.2008.370 · Cited by 242
Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
Sheth, S., Jajoo, S., Kaur, T., Mukherjea, D., Sheehan, K., Rybak, L. P., & Ramkumar, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051655 · Cited by 225
Yang, H.-S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C.-C. H., Tan, T.-H., & Colburn, N. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1297-1306.2006 · Cited by 202
Mudduluru, G., Medved, F., Grobholz, R., Jost, C., Gruber, A., Leupold, J. H., Post, S., Jansen, A., Colburn, N. H., & Allgayer, H. (2007) · Cancer · doi:10.1002/cncr.22983 · Cited by 196
Rapid Culling of the CD4+ T Cell Repertoire in the Transition from Effector to Memory
Williams, M. A., Ravkov, E. V., & Bevan, M. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.014 · Cited by 171
MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma
Liu, C., Yu, J., Yu, S., Lavker, R. M., Cai, L., Liu, W., Yang, K.-G., He, X., & Chen, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.021 · Cited by 165
Leupold, J. H., Yang, H.-S., Colburn, N. H., Asangani, I., Post, S., & Allgayer, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210234 · Cited by 163
Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein
Palamarchuk, A., Efanov, A., Maximov, V., Aqeilan, R. I., Croce, C. M., & Pekarsky, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3469 · Cited by 151
Wang, Q., Sun, Z., & Yang, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210793 · Cited by 149
Wang, Z. (2012) · Oncology Reports · doi:10.3892/or.2012.1682 · Cited by 154
Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions
Matsuhashi, S., Manirujjaman, M., Hamajima, H., & Ozaki, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092304 · Cited by 143
Reis, P. P., Tomenson, M., Cervigne, N. K., Machado, J., Jurišica, I., Pintilie, M., Sukhai, M. A., Perez‐Ordoñez, B., Grenman, R. A., Gilbert, R. W., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-238 · Cited by 141
Fish, J. E., & Marsden, P. A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5421-8 · Cited by 142
Shiota, M., Izumi, H., Tanimoto, A., Takahashi, M., Miyamoto, N., Kashiwagi, E., Kidani, A., Hirano, G., Masubuchi, D., Fukunaka, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2334 · Cited by 134
Zhen, Y., Liu, Z., Yang, H., Yu, X., Wu, Q., Hua, S., Long, X., Jiang, Q., Song, Y., Cheng, C., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.376 · Cited by 131
Nakata, K., Sugi, Y., Narabayashi, H., Kobayakawa, T., Nakanishi, Y., Tsuda, M., Hosono, A., Kaminogawa, S., Hanazawa, S., & Takahashi, K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.788596 · Cited by 137
Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer
Chu, J., Cargnello, M., Topisirović, I., & Pelletier, J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.06.005 · Cited by 135
Papavassiliou, A. G., & Musti, A. M. (2020) · Cells · doi:10.3390/cells9112470 · Cited by 124
Park, Y. M., Hwang, S. J., Masuda, K., Choi, K.-M., Jeong, M., Nam, D., Gorospe, M., & Kim, H. H. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00443-12 · Cited by 127
Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer
Mori (2010) · International Journal of Oncology · doi:10.3892/ijo_00000590 · Cited by 125
Pdcd4, a colon cancer prognostic that is regulated by a microRNA
Allgayer, H. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.09.001 · Cited by 123
The role of Pdcd4 in tumour suppression and protein translation
Wang, Q., & Yang, H. (2018) · Biology of the Cell · doi:10.1111/boc.201800014 · Cited by 113
Wu, H., Kong, L., Tan, Y., Epstein, P. N., Zeng, J., Gu, J., Liang, G., Kong, M., Chen, X., Miao, L., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3958-8 · Cited by 102
Frequent loss of PDCD4 expression in human glioma: Possible role in the tumorigenesis of glioma
Gao, F., Zhang, P., Zhou, C., Li, J., Wang, Q., Zhu, F., Ma, C., Sun, W., & Zhang, L. (2007) · Oncology Reports · doi:10.3892/or.17.1.123 · Cited by 100
Miyanaga, A., Gemma, A., Noro, R., Kataoka, K., Matsuda, K., 奈良, 道., Okano, T., Seike, M., Yoshimura, A., Kawakami, A., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2140 · Cited by 99
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Zhai, Y., Wang, T., Fu, Y., Yu, T., Ding, Y. P., & Nie, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098011 · Cited by 98
Yang, Y., Meng, H., Peng, Q., Yang, X., Gan, R., Zhao, L., Chen, Z., Lu, J., & Meng, Q. H. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.66 · Cited by 96
The Links between Transcription, β-catenin/JNK Signaling, and Carcinogenesis
Saadeddin, A., Babaei‐Jadidi, R., Spencer‐Dene, B., & Nateri, A. S. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0027 · Cited by 85
Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers
Ashrafizadeh, M., Zarrabi, A., Hashemipour, M., Vosough, M., Najafi, M., Shahinozzaman, M., Hushmandi, K., Khan, H. Z., & Mirzaei, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105199 · Cited by 84
Targeting the eIF4A RNA helicase as an anti-neoplastic approach
Chu, J., & Pelletier, J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.006 · Cited by 81
Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
Izzo, S., Naponelli, V., & Bettuzzi, S. (2020) · Nutrients · doi:10.3390/nu12041010 · Cited by 81
Dikshit, B., Irshad, K., Madan, E., Aggarwal, N., Sarkar, C., Chandra, P. S., Gupta, D. K., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2012) · Oncogene · doi:10.1038/onc.2012.393 · Cited by 79
Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
Wei, N., Liu, S. S., Leung, T. H., Tam, K., Liao, X. Y., Cheung, A., Chan, K. K. L., & Ngan, H. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-70 · Cited by 80
The Role of microRNA-21 in the Onset and Progression of Cancer
Singh, A. K., Singh, A. K., Giri, R., Kumar, D., Sharma, R., Vališ, M., Kuča, K., & Garg, N. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0096 · Cited by 81
MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases
Li, S., Liang, Z., Liu, X., & Zou, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1052-6 · Cited by 78
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis
Fassan, M., Pizzi, M., Giacomelli, L., Mescoli, C., Ludwig, K., Pucciarelli, S., & Rugge, M. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1046-5 · Cited by 77
Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA
Wedeken, L., Singh, P., & Klempnauer, K.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269456 · Cited by 75
Self-citationsiRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression
Bitomsky, N., Wethkamp, N., Marikkannu, R., & Klempnauer, K.-H. (2008) · Oncogene · doi:10.1038/onc.2008.115 · Cited by 75
Self-citationYang, F., Liu, M., Li, W., Che, J., WANG, G.-C., & Zheng, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2813 · Cited by 76
PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis
Ludwig, K., Fassan, M., Mescoli, C., Pizzi, M., Balistreri, M., Albertoni, L., Pucciarelli, S., Scarpa, M., Sturniolo, G. C., Angriman, I., et al. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1345-5 · Cited by 67
Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion
Santhanam, A. N., Baker, A. R., Hegamyer, G., Kirschmann, D. A., & Colburn, N. H. (2010) · Oncogene · doi:10.1038/onc.2010.158 · Cited by 67
Gao, F., Wang, X., Zhu, F., Wang, Q., Zhang, X., Guo, C., Zhou, C., Ma, C., Sun, W., Zhang, Y., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00497.x · Cited by 66
MicroRNA-21 suppression impedes medulloblastoma cell migration
Grunder, E., D’Ambrosio, R., Fiaschetti, G., Abela, L., Arcaro, A., Zuzak, T. J., Ohgaki, H., Lv, S., Shalaby, T., & Grotzer, M. A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.041 · Cited by 66
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
Wang, G., Wang, J. J., Tang, H., & To, S. S. T. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.001 · Cited by 67
Luo, X., Gu, J., Zhu, R., Feng, M., Zhu, X., Li, Y., & Fei, J. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-82 · Cited by 65
Xia, H., & Zhao, Y. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1699826 · Cited by 61
Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
Wei, N., Liu, S. S., Chan, K. K. L., & Ngan, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030311 · Cited by 59
Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation
Singh, P., Wedeken, L., Waters, L. C., Carr, M. D., & Klempnauer, K.-H. (2011) · Oncogene · doi:10.1038/onc.2011.202 · Cited by 50
Self-citationHwang, S.-K., Baker, A. R., Young, M. R., & Colburn, N. H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu008 · Cited by 49
MicroRNA-21 promotes pancreatic β cell function through modulating glucose uptake
Liu, R., Liu, C., He, X., Sun, P., Zhang, B., Yang, H., Shi, W., & Ruan, Q. (2022) · Nature Communications · doi:10.1038/s41467-022-31317-0 · Cited by 53
Waters, L. C., Veverka, V., Böhm, M., Schmedt, T., Choong, P. T., Muskett, F. W., Klempnauer, K.-H., & Carr, M. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210305 · Cited by 49
Self-citationNedaeinia, R., Sharifi, M., Avan, A., Kazemi, M., Nabinejad, A., Ferns, G. A., Ghayour-Mobarhan, M., & Salehi, R. (2017) · Tumor Biology · doi:10.1177/1010428317692261 · Cited by 47
Programmed cell death 4 protein in esophageal cancer
Rugge (2010) · Oncology Reports · doi:10.3892/or_00000838 · Cited by 45
Zhen, Y., Li, D., Li, W., Yao, W., Wu, A., Huang, J., Gu, H., Huang, Y., Wang, Y., Wu, J., et al. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14478843952861 · Cited by 44
Effects of quercetin on microRNAs: A mechanistic review
Kordkheyli, V. A., Khonakdar-Tarsi, A., Mishan, M. A., Tafazoli, A., Bardania, H., Zarpou, S., & Bagheri, A. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28663 · Cited by 41
Wang, Q., Zhang, Y., & Yang, H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.004 · Cited by 42
Zhang, X., Wang, X., Song, X., Liu, C., Shi, Y., Wang, Y., Afonja, O., Ma, C., Chen, Y. H., & Zhang, L. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01664.x · Cited by 41
Waters, L. C., Strong, S. L., Ferlemann, E., Oka, O., Muskett, F. W., Veverka, V., Banerjee, S., Schmedt, T., Henry, A. J., Klempnauer, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166157 · Cited by 40
Self-citationBiyanee, A., Ohnheiser, J., Singh, P., & Klempnauer, K.-H. (2015) · Oncogene · doi:10.1038/onc.2014.83 · Cited by 37
Self-citationInhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis
Rodrigues, P. M., Afonso, M. B., Simão, A. L., Borralho, P. M., Rodrigues, C. M. P., & Castro, R. E. (2015) · Scientific Reports · doi:10.1038/srep17528 · Cited by 37
The inhibitory action of PDCD4 in lipopolysaccharide/D-galactosamine-induced acute liver injury
Wang, X., Zhang, L., Wei, Z., Zhang, X., Gao, Q., Ma, Y., Liu, X., Jiang, Y. Z., Liu, X., Guo, C., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2012.174 · Cited by 35
Fehler, O., Singh, P., Haas, A., Ulrich, D., Müller, J. P., Ohnheiser, J., & Klempnauer, K.-H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku800 · Cited by 35
Self-citationProgrammed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis
Fassan, M., Pizzi, M., Battaglia, G., Giacomelli, L., Parente, P., Bocus, P., Ancona, E., & Rugge, M. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.078253 · Cited by 35
Shen, L., Ling, M., Li, Y., Xu, Y., Zhou, Y., Ye, J., Pang, Y., Zhao, Y., Jiang, R., Zhang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057652 · Cited by 33
Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors
Калиниченко, С. В., Kopantzev, E. P., Korobko, E. V., Palgova, I. V., Эдуардовна, З. Л., Mv, B., Petrov, A. N., Frank, G. A., Sverdlov, E. D., & Korobko, I. V. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.03.022 · Cited by 33
Mladenov, M. I., Bogdanov, J. B., Bogdanov, B., Hadzi‐Petrushev, N., Kamkin, A. G., Stojchevski, R., & Avtanski, D. B. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00559-5 · Cited by 32
Wedeken, L., Ohnheiser, J., Hirschi, B., Wethkamp, N., & Klempnauer, K. (2010) · Genes & Cancer · doi:10.1177/1947601910364227 · Cited by 33
Self-citationNedaeinia, R., Avan, A., Ahmadian, M., Nia, S. N., Ranjbar, M., Sharifi, M., Goli, M., Piroozmand, A., Nourmohammadi, E., Manian, M., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26047 · Cited by 32
Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus
Araki, Y., & Mimura, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021019 · Cited by 38
Kumar, N., Wethkamp, N., Waters, L. C., Carr, M. D., & Klempnauer, K.-H. (2013) · Oncogenesis · doi:10.1038/oncsis.2012.37 · Cited by 30
Self-citationChen, B., Huang, S. G., Ju, L., Li, M., Nie, F. F., Zhang, Y., Zhang, Y. H., Chen, X., & Gao, F. (2016) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20155020 · Cited by 30
Iinuma, H. (2012) · Oncology Reports · doi:10.3892/or.2012.1648 · Cited by 30
Fay, M. M., Clegg, J. M., Uchida, K. A., Powers, M. A., & Ullman, K. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541300 · Cited by 30
PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression
Guo, J., Ozaki, I., Xia, J., Kuwashiro, T., Kojima, M., Takahashi, H., Ashida, K., Anzai, K., & Matsuhashi, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00661 · Cited by 29
Mechanisms elevating ORMDL3 expression in recurrent wheeze patients: Role of Ets-1, p300 and CREB
Jin, R., Xu, H., Yuan, W.-X., Zhuang, L., Liu, L., Jiang, L., Zhu, L.-H., Liu, J., & Zhou, G.-P. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.007 · Cited by 29
Paolo, A. D., Eastman, G., Mesquita-Ribeiro, R., Farías, J., Macklin, A. M., Kislinger, T., Colburn, N. H., Munroe, D. J., Sosa, J. R. S., Dajas‐Bailador, F., et al. (2020) · RNA · doi:10.1261/rna.075424.120 · Cited by 29
Tang, C., Liu, Y., Liu, S., Yang, C., Chen, L., Tang, F., Wang, F., Zhan, L., Deng, H., Zhou, W., et al. (2021) · Pharmacology · doi:10.1159/000520311 · Cited by 28
Lobo, V. J. S.-A., Doni, M., Verrecchia, A., Sanulli, S., Fagà, G., Piontini, A., Bianchi, M., Conacci‐Sorrell, M., Mazzarol, G., Peg, V., et al. (2013) · Oncogene · doi:10.1038/onc.2012.621 · Cited by 28
Ahn, J., Choi, J., Won, M., Kang, C., Gyun, M.-R., Park, H., Kim, C., & Chung, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.121 · Cited by 26
Kim, C., Won, M., Choi, C.-H., Ahn, J., Kim, B., Song, K.-B., Kang, C., & Chung, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.012 · Cited by 25
Singh, P. A., Marikkannu, R., Bitomsky, N., & Klempnauer, K. H. (2009) · Oncogene · doi:10.1038/onc.2009.239 · Cited by 24
Self-citationChen, Y., Bian, Y., Zhao, S., Kong, F., & Li, X. (2016) · Oncology Letters · doi:10.3892/ol.2016.5323 · Cited by 22
Zhao, J., Cao, J., Zhou, L., Du, Y., Zhang, X., Yang, B., Gao, Y., Wang, Y., Ma, N., & Yang, W. (2018) · Oncology Letters · doi:10.3892/ol.2018.9307 · Cited by 22
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1
Jèmaà, M., Abassi, Y., Kifagi, C., Fezai, M., Daams, R., Lang, F. J. W., & Massoumi, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-30251-w · Cited by 21
Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
Reyes‐González, J. M., Quiñones‐Díaz, B. I., Santana‐Rivera, Y., Báez, P., Soto, D., Valiyeva, F., Marcos-Martínez, M. J., Thomas, R. J. F.-D., & Vivas‐Mejía, P. E. (2020) · Cancers · doi:10.3390/cancers12040880 · Cited by 19
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin
Franchin, C., Salvi, M., Arrigoni, G., & Pinna, L. A. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.04.002 · Cited by 17
Singh, P., Singh, A. P., Tripathi, S. K., Kumar, V., & Sane, A. P. (2019) · Plant Science · doi:10.1016/j.plantsci.2019.110242 · Cited by 14
Matsuhashi, S. (2011) · Oncology Reports · doi:10.3892/or.2011.1450 · Cited by 15
Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation
Kloos, B., Chakraborty, S., Lindner, S. G., Noack, K., Steffen, U., Schett, G. A., Krämer, O. H., & Kubatzky, K. F. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0117-7 · Cited by 17
Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma
Jiang, Y., Zhang, S. H., Han, G. Q., & Qin, C. Y. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.01.015 · Cited by 14
Pdcd4 tumor suppressor: Properties, functions, and possible applications in oncology
Вихрева, П. Н., Shepelev, M. V., Korobko, E. V., & Korobko, I. V. (2010) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416810020011 · Cited by 15
Lim, S., & Hong, R. (2011) · Oncology Letters · doi:10.3892/ol.2011.365 · Cited by 13
Jo, S.-H., Kim, D. E., Clocchiatti, A., & Dotto, G. P. (2016) · Oncotarget · doi:10.18632/oncotarget.11227 · Cited by 13
Ferris, W. F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903374 · Cited by 11
Metadata
- Authors
- Bitomsky, N., Böhm, M., & Klempnauer, K.-H.
- Affiliations
- University of Münster (DE)
- Corresponding author
- Klempnauer, Karl-Heinz
- Venue
- Oncogene
- Published
- 2004-08-30
- Volume
- 23
- Issue
- 45
- Pages
- 7484-7493
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2081476178
- Cited by
- 134
- References
- 34
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 3 · 2016: 10 · 2015: 5 · 2014: 10 · 2013: 5 · 2012: 9
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Krebshilfe
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- PDCD4, c-Jun, JNK, c-Jun phosphorylation, P300, coactivator recruitment, AP-1 transactivation, tumor suppressor, keratinocyte transformation, lung cancer, protein-protein interaction
- MeSH terms
- Animals, Cell Line, Humans, Nuclear Proteins, Phosphorylation, Protein Binding, Quail, Trans-Activators, RNA-Binding Proteins, Proto-Oncogene Proteins c-jun, Mitogen-Activated Protein Kinase Kinases, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Apoptosis Regulatory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review